29/09/2020

The Netherlands study: Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients

29/09/2020 No Comments

Source: Science Direct A.J.J.LammersaR.M.BrohetbR.E.P.TheunissenaC.KosteraR.RoodcD.W.M.VerhagendK.BrinkmaneR.J.HassingfA.DofferhoffgR.el MoussaouihG.HermanidesiJ.EllerbroekjN.BokhizzoukH.VisserlM.van den BergemH.BaxnD.F.PostmaoP.H.P.Groenevelda aIsala, Zwolle, The NetherlandsbDepartment of Epidemiology and Statistics, Isala Academy, Zwolle, The NetherlandscDiakonessen Hospital, Utrecht, The NetherlandsdMedisch Centrum

Cuba: Early hydroxychloroquine use potent against virus’. Hydroxychloroquine is part of the Cuban protocol for Covid-19 treatment

29/09/2020 No Comments

Source: Anadolu Agency Cuba: Early hydroxychloroquine use potent against virus’ In Cuba, Lage Davila, advisor to the president of BioCubaPharma and Director for the Centre

Spain/US – Brief communication: A meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19 (HCQ reduces the risk of COVID-19 by about 20%)

29/09/2020 No Comments

Source: MedRxiv. Full Study in PDF here Xabier Garcia-Albeniz, Julia Del Amo, Rosa Polo, Jose Miguel Morales Asencio, Miguel A HernanmedRxiv 2020.09.29.20203869; doi: https://doi.org/10.1101/2020.09.29.20203869 Abstract Background: There is disagreement about whether hydroxychloroquine (HCQ) is effective as prophylaxis

The Palmer Foundation

Day: September 29, 2020

The Netherlands study: Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients

Cuba: Early hydroxychloroquine use potent against virus’. Hydroxychloroquine is part of the Cuban protocol for Covid-19 treatment

Spain/US – Brief communication: A meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19 (HCQ reduces the risk of COVID-19 by about 20%)

Copyright 2020 © The Palmer Foundation